首页> 外文期刊>Research journal of pharmacy and technology >Ion Sensitive Floating In Situ gel for Controlled Delivery of Famotidine and Domperidone Maleate for the Treatment of Gastro Oesophageal Reflux Disease
【24h】

Ion Sensitive Floating In Situ gel for Controlled Delivery of Famotidine and Domperidone Maleate for the Treatment of Gastro Oesophageal Reflux Disease

机译:离子敏感漂浮原位凝胶,用于对胃肠嗜热反流疾病治疗胃肠反流疾病的胎素和Domperidone Maleate的控制递送

获取原文
获取原文并翻译 | 示例
           

摘要

The purpose of present investigation was to develop stomach specific floating controlled release in-situ gelling system of Famotidine and Domperidone maleate to treat gastro oesophageal reflux disease. The stomach specific in-situ gel was prepared by ionic gelation method using different polymers of varied concentrations of sodium alginate and hydroxy propyl methyl cellulose K4M. The prepared in-situ gel was characterized for their physical appearance, viscosity, pH, floating behaviour, gelling time, gelling capacity, drug content, and drug release and stability studies. The result of all the parameters indicated that F8 formulation was found better because formulation Fs showed instantaneous gelation when came in contact with 0.1N hydrochloric acid and remain as gel form for few hours. It showed optimum viscosity so were pourable at normal condition. Floating behavior showed highest floating time and the in-vitro release of Famotidine and Domperidone maleate of in-situ gel formulation was found to be 97.45±0.20 and 95.18±0.29 respectively at the end of 12 hours and this formulation was considered as best formulation. All the formulations were subjected to different kinetic investigation such as zero order model, first order model, Higuchi model, Korsmeyer-Peppas model and the result indicated that almost all formulations followed zero order release kinetics with super case II transport mechanism. Stability study was conducted for successful formulation according to ICH guidelines. The results have shown that there was less variation in the physical appearance, drug content and drug release profile.
机译:目前调查的目的是发育胃特异性浮动控制释放原位胶凝系统的法替辛和Domperidone Malate,以治疗胃肠道反流病。通过使用不同浓度的藻酸钠和羟基丙基纤维素K4M的不同聚合物,通过离子凝胶化方法制备胃特异的原位凝胶。制备的原位凝胶的特征在于它们的外观,粘度,pH,浮动行为,胶凝时间,胶凝能力,药物含量和药物释放和稳定性研究。所有参数的结果表明,F8配方较好,因为在与0.1N盐酸接触时显示出瞬时凝胶化合物,并且留下凝胶形式几小时。它显示出最佳粘度,所以在正常情况下倾泻。浮动行为显示出最高的浮动时间和原位凝胶制剂的Famotidine和Domperidone Malate的体外释放,分别在12小时的12小时内分别为97.45±0.20和95.18±0.29,并且该制剂被认为是最佳配方。所有配方都经受不同的动力学调查,如零阶模型,一阶模型,HIGUCHI模型,Korsmeyer-Peppas模型,结果表明,几乎所有配方跟随零级释放动力学,具有超级案例II运输机制。根据ICH指南,对成功制剂进行了稳定性研究。结果表明,物理外观,药物含量和药物释放曲线的变化较小。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号